Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 95547001000001115 | Sebelipase alfa (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 95547101000001119 | Sebelipase alfa | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sebelipase alfa | Is a | Substance with enzyme mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sebelipase alfa 20mg/10ml solution for infusion vials | Has specific active ingredient | False | Sebelipase alfa | Inferred relationship | Existential restriction modifier | |
| Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) | Has specific active ingredient | False | Sebelipase alfa | Inferred relationship | Existential restriction modifier | |
| Sebelipase alfa 20mg/10ml solution for infusion vials 1 vial | Has specific active ingredient | False | Sebelipase alfa | Inferred relationship | Existential restriction modifier | |
| Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial | Has specific active ingredient | False | Sebelipase alfa | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR